GRILLO LOPEZ ANTONIO J 4
4 · ONYX PHARMACEUTICALS INC · Filed Apr 24, 2013
Insider Transaction Report
Form 4
GRILLO LOPEZ ANTONIO J
Director
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2013-04-23−5,000→ 0 totalExercise: $37.68Exp: 2022-03-29→ Common Stock (5,000 underlying) - Exercise/Conversion
Common Stock
2013-04-23$37.68/sh+5,000$188,400→ 11,600 total - Sale
Common Stock
2013-04-23$101.28/sh−5,000$506,400→ 6,600 total
Footnotes (2)
- [F1]Shares sold pursuant to 10b5-1 plan.
- [F2]Fully vested.